此文绝对会颠覆你对阿斯利康疫苗的观念!CFC好文章

lindamy

时代广场舞照跳
VIP
注册
2005-11-23
消息
25,407
荣誉分数
6,321
声望点数
373
有没有人算过不打疫苗死于新冠的几率?
严重反应都是微乎其微,而且死亡的原因很难确定,疫苗贡献多大的比例。

安省截止的4月3日的报道,有5例死亡,可能与疫苗相关。这是我看到的最新报道,油管上有说安省24例死亡,其中13例已经排除疫苗的作用,11例需要进一步调查。

安省疫苗接种人群中发生2528例不良反应,比率是68/10万,其中318例为严重不良反应。没有看到安省三种疫苗各打了多少,所以无法判断不良反应的比率。
辉瑞疫苗不良反应最多:1474,其中严重反应:263;
Moderna疫苗不良反应:1049,其中严重反应:54;
阿斯利康疫苗不良反应:5,其中严重反应:1.


 

贵圈

灭活灭活重组
注册
2014-10-21
消息
18,435
荣誉分数
3,423
声望点数
273

livingeverywhere

你删贴,就说明你特别害怕我说的,相信JB和贺锦丽真赢8100万选票的人,基本上有认知障碍,离他们远点
注册
2008-08-02
消息
10,739
荣誉分数
1,566
声望点数
373
感冒病毒的疫苗,不良反应比例多少,严重反应比例多少?
 

happy 2016

初级会员
注册
2016-01-12
消息
559
荣誉分数
227
声望点数
53
CTV News: Coronavirus: First case of blood clot linked to AstraZeneca vaccine reported in Canada.
"The person was taken care of by the health and social services network and received the care appropriate to their condition," said Quebec's statement. "She is now recovering at her home and there is no fear for her life."
 

happy 2016

初级会员
注册
2016-01-12
消息
559
荣誉分数
227
声望点数
53
"The person was taken care of by the health and social services network and received the care appropriate to their condition," said Quebec's statement. "She is now recovering at her home and there is no fear for her life."
 

ottawa_tj

不知名会员
注册
2015-02-22
消息
10,035
荣誉分数
2,968
声望点数
273
没实验,不和逻辑=呼吸道恶性传染病,戴口罩有害。

腺病毒载体疫苗类似流感疫苗,

如果辉瑞等mRNA疫苗和流感疫苗不冲突(或者没实验过),理论上和阿斯利康也是不冲突。

让德国先实验吧。
 

lindamy

时代广场舞照跳
VIP
注册
2005-11-23
消息
25,407
荣誉分数
6,321
声望点数
373
腺病毒载体疫苗类似流感疫苗,

如果辉瑞等mRNA疫苗和流感疫苗不冲突(或者没实验过),理论上和阿斯利康也是不冲突。

让德国先实验吧。
5 hr 20 min ago

UK ‘mix and match’ vaccine trial expanded to include Moderna and Novavax​

From CNN’s Chloé Adams

A major UK trial to examine whether different coronavirus vaccines can safely be used for two-dose regimens has now been expanded to include the Moderna and Novavax vaccines, with results expected to be reported in a matter of months.

The Oxford Vaccine Group’s Com-Cov study started in February and is the world’s first to examine whether different coronavirus vaccines can safely be used in the two-dose vaccination program.

The study to mix and match Oxford-AstraZeneca and Pfizer-BioNTech vaccines for first and second doses moved into its second stage on Wednesday, and will now expand to offer a combination of the four different vaccines including Moderna and Novavax.

Speaking on BBC Radio 4’s Today program on Wednesday, Matthew Snape of the Oxford Vaccine Group and chief investigator of the Com-Cov study said the results of the trial could be available by the summer -- although no firm date has been released.

“There's some hints from studies that have been done in mice that the combinations of vaccines might actually give a better immune response overall, which would obviously be better,” he said.

The study, funded by the UK government’s Vaccine Task Force and the National Institute for Health Research (NIHR), will look at people from the age of 50 who've already had their first dose of vaccine.

More than 800 people have taken part in the research so far and have received two doses of either Pfizer, AstraZeneca or a mix of both.

Snape told the BBC that the findings could have a huge impact on the vaccine rollout across the world.

If we have flexibility in which vaccines we give for the second dose or even later doses, it massively increases the flexibility and resilience of the immunization program, and would mean we can roll these vaccines out more quickly, not just in the UK but internationally,” Snape said.

The research, described as a single blind study, doesn’t allow the vaccine brand to be disclosed to either the participants receiving the shot or the scientists monitoring the results, who will use blood tests to look for immune responses.

Subjects can visit one of nine study sites across England, with the organizers pushing to recruit people from a variety of ethnic backgrounds and those with pre-existing conditions.

The US Centers for Disease Control and Prevention (CDC) currently warns Covid-19 vaccines are not interchangeable. “We don’t want people to just start mixing and matching with whatever is easiest to get,” said CDC medical officer, Dr. Sarah Mbaeyi during the CDC Clinician Outreach and Communication Activity call in March.

The CDC currently recommends a two dose series for both the Pfizer and Moderna vaccines and advises that vaccines should only be mixed and matched in “exceptional situations.”

The rollout of the Moderna vaccine in the UK started in April. The Novavax vaccine is currently under review by the UK Medicines Healthcare Regulatory Agency (MHRA).
 

lindamy

时代广场舞照跳
VIP
注册
2005-11-23
消息
25,407
荣誉分数
6,321
声望点数
373
3 hr 44 min ago

German Chancellor Angela Merkel gets AstraZenca vaccine​

From CNN's Fred Pleitgen

German Chancellor Angela Merkel speaks on April 16 in Berlin.
German Chancellor Angela Merkel speaks on April 16 in Berlin. Tobias Schwarz/AFP/Getty Images

German Chancellor Angela Merkel received a first dose of the Oxford-AstraZeneca Covid-19 vaccine on Friday, her spokesperson Steffen Seibert said on twitter.

“I am happy that I received the first vaccination with AstraZeneca today. I would like to thank everyone who is involved in the vaccination campaign – and everyone who is vaccinated. Vaccination is the key to overcoming the pandemic,” Seibert said on behalf of Merkel.

The AstraZeneca vaccine has been controversial in Germany with many people initially refusing to take shot because of safety concerns.

In March, Germany announced it would only administer the vaccine to people ages 60 and older on the advice of the country’s vaccine committee. The move followed reports of rare blood clots in the brains of 31 people following a first dose.

##Vaccines
 
顶部